Cranial Electrical Stimulation (CES) as Treatment for Insomnia in Patients With Subacute Stroke
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03344562|
Recruitment Status : Terminated (Due to lack of resources (insufficient personnel) and due to technical problems with measurement of primary and secondary outcomes.)
First Posted : November 17, 2017
Results First Posted : December 19, 2020
Last Update Posted : December 19, 2020
This will be a double blinded randomized clinical trial carried out at Zale-Lipshy and Parkland Hospital Inpatient Rehabilitation Facilities. Acute stroke patients with insomnia, identified by the Insomnia Severity Index (ISI), and who choose to participate in this study will be randomized to CES (Cranial Electrical Stimulation) or sham CES. Patients who do not feel they are getting adequate sleep but want to continue in the study will be given the option to receive the standard of care medication as a rescue starting on the 3rd night.
Patients will receive treatment with a Fisher-Wallace CES device or Sham CES. Treatment with CES will be for 20 minutes once a day, and the treatment period will be for 7 days. Patients will be allowed to increase the intensity of the device from the suggested starting point of level 2 if they feel no improvement in sleep on night 1. Groups will be monitored with a wrist worn actigraph that records the patient's activity for the duration of the period of study and provides data on sleep latency, time spent asleep, and sleep efficiency. The outcome measures will be total minutes/hours of sleep, sleep efficiency and subjective reports of drowsiness using the Karolinska Sleepiness Scale. Actigraphic data will be collected 24 hours a day for 7 days. The total length of study will be about 24 months with a target N of 100 consented individuals and 85 participants. Patients will be allowed to exit the study at any time on their own choosing. To minimize loss of subjects, patients will have the option to choose SOC rescue starting on the third night. Patients who choose the SOC rescue will continue to be monitored with an actigraph for data collection purposes.
The investigator should discontinue study participation for a given subject or withdraw the subject from study if he/she believes that continuation would be detrimental to the subject's well-being. A subject can decide to withdraw from the study at any time and for any reason.
|Condition or disease||Intervention/treatment||Phase|
|Cerebrovascular Accident Sleep Disorder||Device: CES||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||19 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||Cranial Electrical Stimulation (CES) as Treatment for Insomnia in Stroke|
|Actual Study Start Date :||February 21, 2017|
|Actual Primary Completion Date :||December 31, 2019|
|Actual Study Completion Date :||December 31, 2019|
Experimental: CES Active
Active cranial electrical stimulation device
Patients will receive cranial electrical stimulation once a day for 20 minutes over 7 days. They will be allowed to increase the stimulation level on Day 2. A wrist worn actigraph will record sleep. Patients may elect to receive standard of care sleep medication if not satisfied with sleep.
Other Name: Fisher-Wallace Cranial Electrical Stimulation
Sham Comparator: CES Sham
Inactive device identical to the active device.
Patient will receive sham electrical stimulation once a day for 20 minutes over 7 days.
Other Name: Sham cranial electrical stimulation
- Hours of Sleep [ Time Frame: 7- 24 hour periods ]A wrist actigraph will record continuously for 7 days. Primary outcome hours of sleep
- Sleep Efficiency [ Time Frame: 7-24 hour periods ]Determined by wrist actigraphy
- Karolinska Sleepiness Scale [ Time Frame: Daily for 7 days ]Self report for daytime sleepiness with 1 being extremely alert and 10 being extremely sleepy, can't keep awake
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03344562
|United States, Texas|
|Zale Lipshy University Hospital|
|Dallas, Texas, United States, 75390|
|Study Director:||Kathleen R Bell, MD||University of Texas|